Biopharma AI
By
Can AI Reveal the Hidden Biology of Cancer? Aitia and Gustave Roussy Join Forces to Decode Disease Causality for Next-Gen Therapies
Key Highlights: AI Collaboration to Decode Cancer ComplexityIn a bold step to redefine cancer treatment, Aitia, a leader…
Is Juvenescence’s Acquisition of Ro5 the Key to Unlocking AI-Driven Longevity Therapies in 2025?
Key Insights Juvenescence Acquires Ro5 to Bolster AI Capabilities in Drug DiscoveryJuvenescence Limited, a clinical-stage AI-enabled biotech company,…
Can AI Turn Biobank Data into Precision Drug Discovery Gold? Inside the Elucidata–Sapien Biosciences Alliance
Key Highlights Transforming Biobanks into AI-Driven EnginesElucidata, a U.S.-India based AI pioneer in life sciences, and Sapien Biosciences,…
How Will Axxam and Molecular Health’s AI-Powered Alliance Accelerate Target Discovery and De-Risk Drug Development for Pharma?
Key Highlights: Strategic Collaboration Targets Early Drug Discovery BottlenecksAnnounced on June 4, 2025, Molecular Health and Axxam have…
Can ProFound Therapeutics and Novartis’ $750M AI-Driven Cardiovascular Pact Redefine Drug Discovery from the Human Proteome?
Key Highlights AI Meets Proteomics: A New Paradigm in Cardiovascular DiscoveryIn a bold step toward AI-enabled medicine, ProFound…
Is Insilico’s AI-Driven UAE University Alliance the Catalyst for a New Generation of Biotech Talent?
Key Highlights Academic Meets AI Innovation in UAEInsilico Medicine, a leader in generative AI for drug discovery, has…
